Approval of Vykat XR marks the first treatment indicated for hyperphagia in patients with Prader-Willi syndrome.
Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster their global competitiveness.
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“ Quantum BioPharma ” or the “ Company ”), is pleased to announce the appointment of Terry Lynch to its board of directors. Mr. Lynch ...
A Waltham company pulled the plug on a Phase 3 cancer trial, while a different Waltham company continued its leadership ...
A judge has cleared the way for the suspect in the killing of UnitedHealthcare's CEO to get a laptop behind bars if his ...
A troubled Rhode Island biotech with ties to Brown University is losing its new CEO and four of nine board members amid a ...
Marc Forth Steps Down as President and CEO to Pursue Another Opportunity; will remain on the Board of Directors –– Jost Fischer, Chairman of ...
After an IPO this year, Metsera is making its best effort to catch up to obesity drug giants Eli Lilly and Novo Nordisk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback